Victory Capital Management
SYNH

Victory Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Victory Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17,690
Closed -$745K – 2582
2023
Q2 		$745K Sell
17,690
-34
-0.2% -$1.38K ﹤0.01% 1815
2023
Q1 		$631K Sell
17,724
-8,711
-33% -$316K ﹤0.01% 1916
2022
Q4 		$970K Sell
26,435
-6,111
-19% -$242K ﹤0.01% 1756
2022
Q3 		$1.53M Sell
32,546
-293
-0.9% -$18.9K ﹤0.01% 1537
2022
Q2 		$2.35M Buy
32,839
+1,362
+4% +$99.6K ﹤0.01% 1420
2022
Q1 		$2.3M Buy
31,477
+10,405
+49% +$880K ﹤0.01% 1450
2021
Q4 		$2.16M Sell
21,072
-7,616
-27% -$731K ﹤0.01% 1528
2021
Q3 		$2.51M Sell
28,688
-33,205
-54% -$3.01M ﹤0.01% 1529
2021
Q2 		$5.54M Buy
61,893
+1,214
+2% +$103K 0.01% 1305
2021
Q1 		$4.6M Sell
60,679
-47,431
-44% -$3.58M ﹤0.01% 1368
2020
Q4 		$7.37M Sell
108,110
-188
-0.2% -$11.7K 0.01% 1152
2020
Q3 		$5.76M Sell
108,298
-327,244
-75% -$19.5M 0.01% 1169
2020
Q2 		$25.4M Sell
435,542
-1,134,476
-72% -$61M 0.03% 683
2020
Q1 		$61.9M Buy
1,570,018
+891,467
+131% +$52.1M 0.05% 500
2019
Q4 		$40.4M Buy
678,551
+4,442
+0.7% +$239K 0.05% 561
2019
Q3 		$35.9M Buy
674,109
+243,840
+57% +$12.5M 0.05% 574
2019
Q2 		$22M Buy
+430,269
New +$20M 0.04% 582
2018
Q1 		– Sell
-16,026
Closed -$699K – 1942
2017
Q4 		$699K Buy
16,026
+1,798
+13% +$84K ﹤0.01% 1286
2017
Q3 		$744K Buy
14,228
+11,851
+499% +$661K ﹤0.01% 1275
2017
Q2 		$139K Buy
2,377
+356
+18% +$18.5K ﹤0.01% 1612
2017
Q1 		$93K Sell
2,021
-125,812
-98% -$6.26M ﹤0.01% 1662
2016
Q4 		$6.72M Buy
127,833
+125,671
+5,813% +$6.08M 0.02% 740
2016
Q3 		$96K Buy
2,162
+663
+44% +$28.8K ﹤0.01% 1551
2016
Q2 		$57K Buy
1,499
+650
+77% +$28.6K ﹤0.01% 1485
2016
Q1 		$35K Buy
+849
New +$35K ﹤0.01% 1528

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Victory Capital Management's SYNH Position: Q3 2023 in Review

Victory Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 17,690 shares — an estimated $745K sold.

Victory Capital Management first reported a position in SYNH in Q1 2016 and held it in 25 quarters. The position peaked at $61.9M in Q1 2020. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Victory Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Victory Capital Management sold 17,690 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $745K.
  • Victory Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 25 quarters.
  • Victory Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $61.9M in Q1 2020.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Victory Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.